Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7422867
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
granted -
US 7420045
IAPs associated cell cycle proteins, compositions and methods of use
granted -
US 7413870
SAK: modulation of cellular proliferation for treatment of cancer
granted -
US 7410979
Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
granted -
US 7378251
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
granted -
US 7368257
Modulators of lymphocyte activation, Mkk3b compositions and methods of use
granted -
US 7358259
HCV inhibitors and methods of using them
granted -
US 7332484
2,4-pyrimidinediamine compounds and their uses
granted -
US 7332602
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted -
US 7329672
2,4-pyrimidinediamine compounds and their uses
granted -
US 7329671
2,4-pyrimidinediamine compounds and their uses
granted -
US 7326790
Diphenylisoxazole compounds and hydro isomers thereof
granted -
US 7285383
Method for selective inactivation of viral replication
granted -
US 7244576
Modulators of angiogenesis
granted -
US 7241581
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
granted -
US 7220745
Heterocyclic compounds useful to treat HCV
granted -
US 7208289
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
granted -
US 7157473
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted -
US 7153880
Substituted diphenyl heterocycles useful for treating HCV infection
granted -
US 7141434
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
granted -
US 7122542
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
granted -
US 7060827
Intermediates useful for making 2,4-pyrimidinediamine compounds
granted -
US 7045284
Method for selective inactivation of viral replication
expired -
US 6979549
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
expired